
Promega and Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, have partnered, the companies recently announced.
According to a release, the partnership will expand Addgene’s vast plasmid repository with the launch of the Promega Plasmid Collection. This provides industry and academic researchers with broad access to reliable, high-value plasmids designed for studying target engagement, protein-protein interactions and targeted protein degradation.
“We are excited to collaborate with Addgene to increase access to plasmids developed through decades of innovation in bioluminescent technologies at Promega,” Promega Senior Director of Life Science Product Management & Marketing Vanessa Ott said in a statement. “Designed through real-world assay development, these tools offer performance and reliability. This partnership enables researchers to integrate the plasmids into their workflows more efficiently and helps translate ideas into answers more quickly across academic and industrial research.”
The initial launch of the Promega Plasmid Collection includes 300 plasmids and the company plans to add an estimated 300 more plasmids in the coming months.
